As of 2024-07-27, the Relative Valuation of Exact Sciences Corp (EXAS) is (48.23) USD. This relative valuation is based on P/E multiples. With the latest stock price at 45.30 USD, the upside of Exact Sciences Corp based on Relative Valuation is -206.5%.
The range of the Relative Valuation is (46.76) - (56.02) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 35.9x - 51.6x | 40.0x |
| Forward P/E multiples | 32.8x - 43.0x | 34.1x |
| Fair Price | (46.76) - (56.02) | (48.23) |
| Upside | -203.2% - -223.7% | -206.5% |
| Date | P/E |
| 2024-07-26 | -34.80 |
| 2024-07-25 | -37.15 |
| 2024-07-24 | -36.76 |
| 2024-07-23 | -37.95 |
| 2024-07-22 | -37.00 |
| 2024-07-19 | -35.96 |
| 2024-07-18 | -36.54 |
| 2024-07-17 | -37.93 |
| 2024-07-16 | -38.16 |
| 2024-07-15 | -36.15 |
| 2024-07-12 | -35.62 |
| 2024-07-11 | -34.45 |
| 2024-07-10 | -34.82 |
| 2024-07-09 | -33.87 |
| 2024-07-08 | -34.72 |
| 2024-07-05 | -34.24 |
| 2024-07-03 | -33.18 |
| 2024-07-02 | -33.17 |
| 2024-07-01 | -32.60 |
| 2024-06-28 | -32.46 |
| 2024-06-27 | -34.18 |
| 2024-06-26 | -33.93 |
| 2024-06-25 | -31.78 |
| 2024-06-24 | -32.23 |
| 2024-06-21 | -34.46 |
| 2024-06-20 | -33.80 |
| 2024-06-18 | -32.21 |
| 2024-06-17 | -31.75 |
| 2024-06-14 | -32.17 |
| 2024-06-13 | -32.84 |
| 2024-06-12 | -32.37 |
| 2024-06-11 | -32.37 |
| 2024-06-10 | -32.95 |
| 2024-06-07 | -32.98 |
| 2024-06-06 | -34.32 |
| 2024-06-05 | -34.99 |
| 2024-06-04 | -33.38 |
| 2024-06-03 | -34.43 |
| 2024-05-31 | -34.92 |
| 2024-05-30 | -34.76 |
| 2024-05-29 | -34.43 |
| 2024-05-28 | -36.12 |
| 2024-05-24 | -38.29 |
| 2024-05-23 | -41.55 |
| 2024-05-22 | -41.09 |
| 2024-05-21 | -41.12 |
| 2024-05-20 | -39.18 |
| 2024-05-17 | -38.70 |
| 2024-05-16 | -39.91 |
| 2024-05-15 | -40.98 |